CJC-1295 w/ DAC 2mg – Long-Acting GHRH Analog | Prime Peptides Care

Prime Peptides Care CJC-1295 w/ DAC 2mg is a long-acting, high-purity research peptide designed for advanced studies on growth hormone–releasing hormone (GHRH) pathways. This synthetic analog incorporates a Drug Affinity Complex (DAC) that allows it to bind to albumin in experimental systems, extending its half-life far beyond standard GHRH peptides and making it ideal for protocols that require sustained growth hormone stimulation.

Each vial contains 2mg of CJC-1295 with DAC, synthesized from the first 29 amino acids of native GHRH with targeted substitutions and a specialized lysine linker for DAC attachment. This molecular design enhances stability, resistance to enzymatic breakdown, and receptor affinity, providing a reliable tool for investigating prolonged growth hormone and IGF-1 responses, pulsatile versus sustained secretion patterns, and long-acting anabolic signaling in controlled models.

Prime Peptides Care supplies this peptide as a lyophilized powder for convenient storage and precise reconstitution. When stored and handled according to standard peptide protocols, CJC-1295 w/ DAC maintains its structural integrity and performance across multiple experimental runs. This product is intended strictly for in‑vitro research use only and is not for human or veterinary use.